On 12 June 2015, Corynebacterium diphtheriae was identified in a skin swab from a burns patient in Scotland. The isolate was confirmed to be genotypically and phenotypically toxigenic. Multilocus sequence typing of three patient isolates yielded sequence type ST 125. The patient was clinically well. We summarise findings of this case, and results of close contact identification and screening: 12 family and close contacts and 32 hospital staff have been found negative for C. diphtheriae. On 9 June 2015, a 20 year old female patient had routine swabs taken from the discharge of recent wounds, following reconstructive surgery. The samples subsequently grew Corynebacterium diphtheriae.
Case report
The patient had contracted severe 30% burns to her face, neck, chest, arms, and thighs as a child. She was followed up regularly by the plastic surgery team for management of burn contractures and skin grafts, and had no other relevant past medical history. On examination her wounds were not erythematous or ulcerated, and appearances were consistent with satisfactory healing.
The patient's childhood vaccination history was fully up to date as per the UK (UK) childhood vaccination schedule recommended [1] , and included vaccination for C. diphtheriae infection.
Further questioning revealed no history of foreign travel at all in preceding years, or of close contacts who had travelled abroad, and there was no known animal contact. The patient had no clinical features of cardiological, neurological or cutaneous manifestations of C diphtheriae. She reported a sore throat which was unremarkable on clinical examination with no membrane present. Following confirmation on 12 June of C. diphtheriae in swabs taken on 9 June, the patient was commenced on oral erythromycin 500mg, six hourly as per Public Health England (PHE) guidelines for the public health control and management of diphtheria. The treatment only started on 16 June, after some delays. The treatment continued for 14 days [2] and booster vaccinations were arranged. As the patient was very well, antitoxin was not administered.
Throat swabs and repeat skin swabs taken on 16 June, again grew toxigenic C. diphtheriae. Results were available on 19 th June and were identified by using MALDI-TOF and Hoyle's Tellurite agar.
Nose, wound and throat swabs were taken on 22 and 23 June. The results of the swabs were available on 26 June and were all negative for C. diphtheriae.
Laboratory findings
The organism was initially identified on the 12 June, by matrix-associated laser desorption ionisation time-offlight (MALDI-TOF) machine used for automated identification of microorganisms (Bruker); with a MALDI score of 99.9%. This test was repeated and a Gram-stain demonstrated Gram-positive bacilli. Hoyle's Tellurite agar and the API Coryne system (bioMérieux) were subsequently used to confirm the identity of the strain as C. diphtheriae. The isolate was then sent to the PHE diphtheria national reference laboratory in Colindale, where it was confirmed as PCR-positive for the toxA gene, and phenotypically positive for toxin production by the Elek immunodiffusion test. The two later isolates from the throat and wound swabs were also confirmed as C. diphtheriae, tox-A -positive and Elek-positive. The genotypic relationship of all three C. diphtheriae isolates was characterised using the multilocus sequence typing (MLST) scheme described by Bolt et al. [3] comprising the seven C. diphtheriae housekeeping genes atpA, dnaE, dnaK, fusA, leuA, odhA, and rpoB. Allelic Antibiotic susceptibility testing was undertaken using Clinical and Laboratory Standards Institute breakpoints [4] and the isolate tested sensitive to erythromycin, ciprofloxacin, meropenem, vancomycin, clindamycin, and clarithromycin. It was of intermediate sensitivity to penicillin. EUCAST breakpoints were not used due to lack of definitive breakpoints for C. diphtheriae.
Contact tracing
A timeline was prepared by our infection control team in conjunction with the clinical and public health teams, using the maximal incubation period of 10 days as a guide (Figure) , with the caveat that the patient reported increased discharge from the wound before 31 May. The patient had spent most of this time as an outpatient at home, with the exception of being an inpatient for one day at the start of the lookback period, and presented to our clinic on 9 June 2015. Contact tracing was undertaken on all 12 family and other close contacts; this included friends, partner and relatives. Additionally, 32 hospital staff were identified as having had a relevant exposure during the patient's inpatient stay, such as being involved with changing wound dressings. Nose and throat swabs were taken from all of them, and Hoyle's Tellurite agar and MALDI-TOF techniques were used to screen specifically for the organism.
The vaccination histories of the patient's two year old child, family contacts as well as all hospital staff contacts, were checked and found to be complete as per UK recommendations. All identified family and close contacts and hospital staff were commenced on chemoprophylaxis with erythromycin at British National Formulary recommended doses, and excluded from work and encouraged to self-isolate until swab results were confirmed as negative. All contacts tested negative.
A memorandum was sent to all medical and nursing staff to enquire about recent foreign travel to exclude a hospital acquired infection.
The source of the organism remains unidentified.
Discussion
C. diphtheriae is an aerobic Gram-positive bacillus with a worldwide distribution. It causes diphtheria, a potentially life-threatening upper respiratory tract infection with a mortality rate of 5-10% in untreated cases [2, 4, 5] . As it is a vaccine preventable illness, it is now very rare in the European Union. Classic diphtheria is caused by bacteriophage-associated exotoxin-producing strains resulting in necrosis of infected cells and a classic fever, sore throat and tonsillar membrane. Non-toxigenic strains usually cause a milder illness or asymptomatic colonisation. Other manifestations of disease include cardiac syndromes (such as myocarditis), cutaneous lesions as well as neurological syndromes [5] [6] [7] .
Humans are the main reservoir and transmit infection via respiratory droplets as well as direct contact. Respiratory and contact precautions are therefore required in an inpatient setting. The incubation period ranges from 1 to 10 days, and untreated individuals may be infectious for 2 to 4 weeks [2, 5] . Treatment includes intravenous or oral macrolide therapy, intramuscular penicillin and antitoxin in severe illness. and the majority of these are subsequently shown to be non-toxigenic [9, 10] .
Of 272 C. diphtheriae strains confirmed by the national reference laboratory from 2010 to 2014, 69% were C. diphtheriae biovar gravis, 26% biovar mitis, and 4% biovar belfanti [11] . The strains from this case were all biovar mitis. The main risk factor for infection with toxigenic C. diphtheriae infection in the UK is travel to an endemic area or contact with others returning from such an area. For toxigenic C. ulcerans infection, the main risk factor is contact with animals including companion animals [9, 10] . Neither the case nor the contacts had travelled abroad or had any animal contact. [8] , from a patient with a chronic leg ulcer from a prosthetic knee infection. Interestingly, this latter patient had themselves lived on a Polynesian island. The source of the organism for the case described here remains unclear, and little is known of the true epidemiology in Scotland.
